CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-02 | Schmid John P. Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-02-02 | RENTON HOLLINGS Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-02-02 | Lydon Nicholas Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-02-02 | Gallagher Carol Giltner Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-01-26 | Piscitelli Dominic Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +23,000 | 23,000 | ||
| 2018-01-26 | Londei Marco Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2018-01-26 | Suria Hamza President, CEO | Grant or award · Employee Stock Option (right to buy) | +63,000 | 63,000 | ||
| 2017-08-22 | Ware J. Anthony Director | Grant or award · Director Stock Option (right to buy) | +28,571 | 28,571 | ||
| 2017-08-22 | Ware J. Anthony Director | Grant or award · Director Stock Option (right to buy) | +10,694 | 10,694 | ||
| 2017-08-21 | Novo Holdings A/S 10% owner | Sale | −356,300 | $21.10 | $7.5M | 1,936,604 |
| 2017-08-15 | Novo Holdings A/S 10% owner | Sale | −143,428 | $21.00 | $3.0M | 2,292,904 |
| 2017-08-14 | Novo Holdings A/S 10% owner | Sale | −35,172 | $21.79 | $766K | 2,436,332 |
| 2017-08-07 | Novo Holdings A/S 10% owner | Sale | −480,000 | $21.10 | $10.1M | 2,472,527 |
| 2017-08-07 | Novo Holdings A/S 10% owner | Sale | −1,023 | $22.92 | $23K | 2,471,504 |
| 2017-08-04 | Novo Holdings A/S 10% owner | Sale | −10,271 | $22.00 | $226K | 2,952,527 |
| 2017-08-03 | Novo Holdings A/S 10% owner | Sale | −21,451 | $22.01 | $472K | 2,962,798 |
| 2017-08-02 | Novo Holdings A/S 10% owner | Sale | −25,700 | $23.87 | $613K | 2,984,249 |
| 2017-08-01 | Novo Holdings A/S 10% owner | Sale | −23,555 | $23.87 | $562K | 3,009,949 |
| 2017-07-26 | Avalon Ventures VII L P 10% owner | Other disposition | −399,987 | 1,636,945 | ||
| 2017-07-26 | Avalon Ventures VII L P 10% owner | Other acquisition | +37,040 | 37,040 |
Page 32 of 36 · 714 trades